๐Ÿ“ข New Earnings In! ๐Ÿ”

Seer, Inc.

SEER

Healthcare
Biotechnology
US

Company Overview

Detailed information about Seer, Inc.

Basic Information
Ticker: SEER
Country: US
Headquarter: Redwood City, CA
Employees: 134
Financial Information
Market Cap: $128.9 Million
Currency: USD
Sector: Healthcare
Industry: Biotechnology

Stock Data provided by Financial Modeling Prep

Company Description

Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic research, and clinical trials. The company intends to sell its products for research purposes, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. It has a collaboration agreement with Discovery Life Sciences, LLC. and the Salk Institute for Biological Studies. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.

Last Updated: Jul 2025

Here's what you can ask